HIV & Co-Infections

HIV co-infection worsens the histological course of other viral infections, such as HCV by increasing and accelerating the risk of cirrhosis or leading to rare but lethal fibrosing cholestatic hepatitis. Discover the latest research on HIV co-infection.

October 29, 2020

DEVELOPMENT OF A MATHEMATICAL MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF THE RYAN WHITE HIV/AIDS PROGRAM

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Ravi GoyalBoyd Gilman
October 27, 2020
Open Access

Frequency, risk factors and mediators of frailty transitions during long-term follow-up among people with HIV and HIV-negative AGEhIV Cohort participants

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Eveline VerheijGregory D Kirk
October 23, 2020
Open Access

Rapid Adaptation of HIV Treatment Programs in Response to COVID-19 - Namibia, 2020

MMWR. Morbidity and Mortality Weekly Report
Steven Y HongEric J Dziuban
October 22, 2020
Open Access

Diagnoses of syphilis and HIV infection during the COVID-19 pandemic in Taiwan

Sexually Transmitted Infections
Chun-Chieh ChiaChih-Cheng Lai
October 20, 2020

0.1. Association of plasma sVCAM-1 and sCD14 with mortality in HIV-1 infected West African adults with high CD4 counts

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Roseline AffiLaurence Weiss
October 23, 2020

Prevalence of human immunodeficiency virus among pulmonary tuberculosis patients: a cross-sectional study

Microbiology and Immunology
Ehssan H O MogladHisham N Altayb
October 29, 2020
Open Access

Social stigma associated with TB and HIV/AIDS among Kudumbashree members: A crosssectional study

Journal of Family Medicine and Primary Care
Leyanna Susan GeorgeAnil Kumar
October 23, 2020
Review
Open Access

Novel Strategies to Combat CMV-Related Cardiovascular Disease

Pathogens & Immunity
Elena VasilievaMichael L Freeman
October 27, 2020

Profiles of HIV Care Disruptions Among Adult Patients Lost to Follow-up in Zambia: A Latent Class Analysis

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Aaloke ModyElvin H Geng
October 26, 2020
Preprint
Open Access

Characterization of Mycobacterium tuberculosis-specific Th22 cells and the effect of tuberculosis disease and HIV co-infection

MedRxiv : the Preprint Server for Health Sciences
Wendy A. BurgersR. J. Wilkinson
October 28, 2020
Review
Open Access

Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases

The Indian Journal of Medical Research
Surendra K Sharma, Vishwanath Upadhyay
October 24, 2020

DRUG OVERDOSE DEATHS AMONG PEOPLE WITH HIV IN NEW YORK CITY, 2007-2017

Journal of Acquired Immune Deficiency Syndromes : JAIDS
S L BraunsteinD Daskalakis
October 25, 2020
Open Access

The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India

BMC Public Health
Ivan MarbaniangVidya Mave
October 16, 2020
Open Access

Human pegivirus (HPgV, GBV-C) RNA in volunteer blood donors from a public hemotherapy service in Northern Brazil

Virology Journal
Aniel de Sarom Negrão SilvaPatrícia Danielle Lima de Lima

Sign up to follow this feed and discover related papers.

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

Bacillus Cereus Infection

Bacillus Cereus is a gram-positive bacteria that is the cause of some foodborne illnesses and leads to diarrhea and vomiting. Discover the latest research on Bacillus Cereus Infection here.

© 2020 Meta ULC. All rights reserved
/feed-previews/hiv-co-infections/4750b477-54c1-4a98-9fef-0f656783a47a